Methodological needs in the quality and safety characterisation of nanotechnology-based health products: Priorities for method development and standardisation

Autor: Halamoda-Kenzaoui, B., Vandebriel, R.J., Howarth, A., Siccardi, M., David, C.A.W., Liptrott, N.J., Santin, M., Borgos, S.E., Bremer-Hoffmann, S., Caputo, F.

Publikováno v: In Journal of Controlled Release 10 August 2021 336:192-206

Physiologically based pharmacokinetic modeling of drug-drug interactions between ritonavir-boosted atazanavir and rifampicin in pregnancy.

Autor: Atoyebi S; Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK., Montanha MC; Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK., Nakijoba R; Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda., Orrell C; Desmond Tutu Health Foundation, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.; Department of Medicine, University of Cape Town, Cape Town, South Africa., Mugerwa H; Joint Clinical Research Centre, Kampala, Uganda., Siccardi M; Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK., Denti P; Division of Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Waitt C; Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK.; Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda.

Publikováno v: CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2024 Nov; Vol. 13 (11), pp. 1967-1977. Date of Electronic Publication: 2024 Nov 08.

N=1* model superpotential revisited (IR behaviour of N=4 limit)

Autor: Arnone, S., Di Segni, G., Siccardi, M., Yoshida, K.

Publikováno v: Int.J.Mod.Phys.A22:5089-5115,2007

The one-loop contribution to the superpotential, in particular the Veneziano-Yankielowicz potential in N=1 supersymmetric Yang-Mills model is discussed from an elementary field theory method and the matrix model point of view. Both approaches are bas

Externí odkaz: http://arxiv.org/abs/0706.3169

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Pharmacokinetics and Safety of Twice-daily Ritonavir-boosted Atazanavir With Rifampicin.

Autor: Gausi K; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Mugerwa H; Joint Clinical Research Centre, Research Department, Kampala, Uganda., Siccardi M; Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, United Kingdom., Montanha MC; Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, United Kingdom., Lamorde M; Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda., Wiesner L; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., D'Avolio A; Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, Turin, Italy., McIlleron H; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Wilkins E; North Manchester General Hospital, HIV Research Unit, Manchester, United Kingdom., De Nicolò A; Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, Turin, Italy., Maartens G; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Khoo S; Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, United Kingdom., Kityo C; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Denti P; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Waitt C; Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, United Kingdom.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 May 15; Vol. 78 (5), pp. 1246-1255.